✦ LIBER ✦

Bcl-xL inhibits p53- but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line

✍ Scribed by Remilio A.L. Schoop; Klaas Kooistra; Robert J. Baatenburg de Jong; Mathieu H.M. Noteborn

Publisher: John Wiley and Sons
Year: 2004
Tongue: French
Weight: 174 KB
Volume: 109
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.11675

No coin nor oath required. For personal study only.

✦ Synopsis

Nonfunctional p53 and especially upregulation of Bcl-x(L) result in advanced disease and poor prognosis of patients suffering head and neck squamous cell carcinoma (HNSCC). Aberrancies of Bcl-x(L) and/or p53 in HNSCC lead to inability of anticancer drugs to induce apoptosis. Bcl-x(L) and/or mutated p53 inhibit the apoptotic process by preventing the mitochondrial release of cytochrome c and/or activation of execution caspases. Here, we report that expression of the avian virus-derived apoptin protein resulted in induction of apoptosis in the HNSCC-derived cell line UMSSC-14B despite the presence of nonfunctional p53. Apoptin activated the execution caspase 3 and induced the release of mitochondrial cytochrome c. Upregulation of Bcl-x(L) in UMSCC-14B cells did not interfere with the apoptin-induced apoptosis, whereas it clearly negatively affected the p53-induced one. Bcl-x(L) significantly decreased the p53-induced cytochrome c release, but not the apoptin-triggered one. Our data demonstrate that apoptin induces apoptosis independent of Bcl-x(L) and p53 and may constitute a potential therapeutic agent for treatment of HNSCC.

📜 SIMILAR VOLUMES

p53 apoptotic response to DNA damage dep

p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines

✍ David L. Crowe; Uttam K. Sinha 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 1 views

Background. In many tumors, the p53 gene has been mutated or deleted. p53 null mutant mice are prone to development of a variety of neoplasms at an early age. In head and neck cancer, p53 mutations are detected in most cases. p53 has been shown to induce growth arrest, differentiation, and death whe

Bcl-xL and Bcl-2 expression in squamous

Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck

✍ John C. Pena; Craig B. Thompson; Wendy Recant; Everett E. Vokes; Charles M. Rudi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 2 views

## Background: Inhibition of apoptosis, or programmed cell death, may be critical both in the development of cancer and in determining response to therapy. the authors examined the expression of two related apoptotic inhibitors, bcl-2 and bcl-xl, in pretreatment biopsies from a series of 42 patient

P53 mutation correlates with cisplatin s

P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines

✍ Carol R. Bradford; Shaobo Zhu; Haruko Ogawa; Tetsuya Ogawa; Matthew Ubell; Ajita 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

## Background: A critical factor for successful organ preservation treatment in head and neck cancer may be selecting tumors that respond to chemotherapy and radiation. previous results in patients indicated that tumors that overexpressed p53 were more sensitive to chemotherapy than those that did

Induction of apoptosis in head-and-neck

Induction of apoptosis in head-and-neck squamous carcinoma cells by γ-irradiation and bleomycin is p53-independent

✍ Vyomesh Patel; John F. Ensley; J. Silvio Gutkind; W. Andrew Yeudall 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 201 KB 👁 1 views

We have examined the ability of gamma-irradiation and bleomycin to induce apoptosis in a model system consisting of cell lines derived from naturally occurring human head-and-neck squamous-cell carcinomas with contrasting p53 status and expression levels of pro- and anti-apoptotic molecules. Followi